Cargando…

Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative (18)F FDG-PET/CT metrics

This study investigated the relationship between epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in non-small-cell lung cancer (NSCLC) and quantitative FDG-PET/CT parameters including tumor heterogeneity. 131 patients with NSCLC underwent stagi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minamimoto, Ryogo, Jamali, Mehran, Gevaert, Olivier, Echegaray, Sebastian, Khuong, Amanda, Hoang, Chuong D., Shrager, Joseph B., Plevritis, Sylvia K., Rubin, Daniel L., Leung, Ann N., Napel, Sandy, Quon, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581070/ https://www.ncbi.nlm.nih.gov/pubmed/28881771 http://dx.doi.org/10.18632/oncotarget.17782

Ejemplares similares

Predictive radiogenomics modeling of EGFR mutation status in lung cancer
por: Gevaert, Olivier, et al.
Publicado: (2017)

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma
por: Minamimoto, Ryogo, et al.
Publicado: (2016)

A radiogenomic dataset of non-small cell lung cancer
por: Bakr, Shaimaa, et al.
Publicado: (2018)

Non–Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications
por: Zhou, Mu, et al.
Publicado: (2018)

A Rapid Segmentation-Insensitive “Digital Biopsy” Method for Radiomic Feature Extraction: Method and Pilot Study Using CT Images of Non–Small Cell Lung Cancer
por: Echegaray, Sebastian, et al.
Publicado: (2016)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI
por: Iagaru, Andrei, et al.
Publicado: (2015)

Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review
por: Minamimoto, Ryogo
Publicado: (2022)

[18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non–Small Cell Lung Cancer
por: Mattonen, Sarah A., et al.
Publicado: (2019)

Whole-body simultaneous time-of-flight PET-MRI: early experience with clinical studies
por: Minamimoto, Ryogo, et al.
Publicado: (2015)

The potential of TOF PET-MRI for reducing artifacts in PET images
por: Iagaru, Andrei, et al.
Publicado: (2015)

Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI
por: Minamimoto, Ryogo, et al.
Publicado: (2017)

Quantitative imaging feature pipeline: a web-based tool for utilizing, sharing, and building image-processing pipelines
por: Mattonen, Sarah A., et al.
Publicado: (2020)

Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
por: Toyama, Yoshitaka, et al.
Publicado: (2020)

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2014)

Pancancer analysis of DNA methylation-driven genes using MethylMix
por: Gevaert, Olivier, et al.
Publicado: (2015)

Early Detection of Lung Cancer in the NLST Dataset
por: Mukherjee, Pritam, et al.
Publicado: (2023)

Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014)

Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI
por: Hotta, Masatoshi, et al.
Publicado: (2018)

Proliferation PET/CT Imaging of Salivary Gland Tumor
por: Minamimoto, Ryogo
Publicado: (2021)

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data
por: Minamimoto, Ryogo
Publicado: (2022)

Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

Cell Proliferation PET Imaging with 4DST PET/CT in Colorectal Adenocarcinoma and Adenoma
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

(18)F-FDG and (11)C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study
por: Minamimoto, Ryogo, et al.
Publicado: (2019)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

KRAS above and beyond – EGFR in pancreatic cancer
por: Siveke, Jens T., et al.
Publicado: (2012)

11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier
por: Hotta, Masatoshi, et al.
Publicado: (2019)

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Tateishi, Kensuke, et al.
Publicado: (2020)

A Shallow Convolutional Neural Network Predicts Prognosis of Lung Cancer Patients in Multi-Institutional CT-Image Data
por: Mukherjee, Pritam, et al.
Publicado: (2020)

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
por: Ramteke, Manoj P., et al.
Publicado: (2016)

Machine learning with multimodal data for COVID-19
por: Chen, Weijie, et al.
Publicado: (2023)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

Comparison of (11)C-4′-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma
por: Okasaki, Momoko, et al.
Publicado: (2014)

CS-03 BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Hayashi, Takahiro, et al.
Publicado: (2020)

External Beam Radiotherapy in Advanced Pheochromocytoma and Paraganglioma: An Observation of a Rare Abscopal Effect
por: Terakawa, Aiko, et al.
Publicado: (2023)

Long fasting is effective in inhibiting physiological myocardial (18)F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis
por: Morooka, Miyako, et al.
Publicado: (2014)

(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study
por: Minamimoto, Ryogo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lje0jduuv55bo8c2gk3t7h49g1